We analyzed data from The Cancer Genome Atlas (TCGA) and found that the expression levels of HSPD1 mRNA were elevated in GBM, prostate cancer, colon cancer, and decreased in ccRCC (Supplementary Fig. S5). The gene discussed is HSPD1; the disease is prostate carcinoma.